Mission
One in four dogs develops cancer. For the most common malignancies — appendicular osteosarcoma, splenic hemangiosarcoma, multicentric lymphoma, high-grade mast cell tumor — the standard of care has not meaningfully changed in fifteen years.
We are changing that — with software a pet parent can actually use, with a workspace veterinarians actually fit into their day, and with AI infrastructure that the partner vet-school network can co-develop.
How we work
Pet parents pay nothing, ever. Veterinarians get free atlas access and case submission. Revenue lives at the partner and pharma side, where institutional budgets exist.
Owner-facing articles are general education with sources. We never make individual treatment recommendations. As clinical-review partnerships are signed, named reviewers will appear at the top of every article.
Case studies ship with run IDs, model versions, and ledger hashes. If you want to audit a result, you can.
What we will not do
Team
Founder of IndieBio (one of the most active biotech accelerators globally), Berkeley BioLabs, and Wild Earth. Twenty years building bio + AI companies; explicit mandate to apply frontier ML to vet oncology.
Founding Engineer and additional senior hires closing in Q3. See open roles →